BackCellular Biomedicine Group Overview

Cellular Biomedicine Group EBIT

EBIT (Earnings Before Interest and Taxes) analysis for CBMG.

Quarterly EBIT

-$17.04M
↓ 7.4% YoY

As of Sep 30, 2020

Annual EBIT (TTM)

-$54.80M
↓ 19.63% YoY

Trailing 12 months ending Sep 30, 2020

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin